Golimumab (Simponi) for inflammatory arthritis

Mark Abramowicz, Gianna Zuccotti, Jean Marie Pflomm, Susan M. Daron, Blaine M. Houst, Corinne E. Zanone, Jules Hirsch, Gerald L. Mandell, Dan M. Roden, Carl W. Bazil, Vanessa K. Dalton, Eric J. Epstein, David N. Juurlink, Richard B. Kim, Hans Meinertz, Sandip K. Mukherjee, F. Estelle R. Simons, Jordan W. Smoller, Neal H. Steigbigel, Donna GoodsteinAmy Faucard, Cynthia Macapagal Covey, Susie Wong, Liz Donohue, Cheryl Brown, Gene Carbona, Cristine Romatowski, Joanne F. Valentino, Yosef Wissner-Levy

Research output: Contribution to journalShort survey

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)55-56
Number of pages2
JournalMedical Letter on Drugs and Therapeutics
Volume51
Issue number1316
StatePublished - Jul 13 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Abramowicz, M., Zuccotti, G., Pflomm, J. M., Daron, S. M., Houst, B. M., Zanone, C. E., Hirsch, J., Mandell, G. L., Roden, D. M., Bazil, C. W., Dalton, V. K., Epstein, E. J., Juurlink, D. N., Kim, R. B., Meinertz, H., Mukherjee, S. K., Simons, F. E. R., Smoller, J. W., Steigbigel, N. H., ... Wissner-Levy, Y. (2009). Golimumab (Simponi) for inflammatory arthritis. Medical Letter on Drugs and Therapeutics, 51(1316), 55-56.